Author:
Seymour J F,Kim D W,Rubin E,Haregewoin A,Clark J,Watson P,Hughes T,Dufva I,Jimenez J L,Mahon F-X,Rousselot P,Cortes J,Martinelli G,Papayannidis C,Nagler A,Giles F J
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Cooper S, Giles FJ, Savona MR . Overcoming resistance in chronic myelogenous leukemia. Leuk Lymphoma 2009; 50: 1785–1793.
2. Rowley JD . Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining. Nature 1973; 243: 290–293.
3. Fava C, Rege-Cambrin G, Saglio G . Chronic myeloid leukemia: state of the art in 2012. Curr Oncol Rep 2012; 14: 379–386.
4. Giles FJ, Swords RT, Nagler A, Hochhaus A, Ottmann OG, Rizzieri DA et al. MK-0457, an Aurora kinase and BCR-ABL inhibitor, is active in patients with BCR-ABL T315I leukemia. Leukemia 2013; 27: 113–117.
5. Hochhaus A . Imatinib mesylate (Glivec, Gleevec) in the treatment of chronic myelogenous leukemia (CML) and gastrointestinal stromal tumors (GIST). Ann Hematol 2004; 83 (Suppl 1): S65–S66.
Cited by
59 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献